Telemedicine Follow-up for Routine, Low-Risk Oculoplastic Surgery

Status: Unknown status
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The investigators propose utilizing a simple telemedical protocol to allow patients to substitute the first post-operative visit with a remote survey that includes essential post-operative history, vision measurement, and photographs, all of which can be provided using a personal computer, tablet, or smart phone. The investigators have selected for this purpose a subset of oculoplastic procedures involving the eyelid and lacrimal system that have well-reported low rates of serious complications, since high-risk procedures will likely always require close, in-person care. The investigators hypothesize that telemedicine follow-up for the first post-operative week after low-risk oculoplastic surgery will decrease the time burden on patients without compromising their satisfaction or increase the risk of late post-operative complications.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Are age 18 years or older

• Are fluent in English

• Own or have ready access to a smart phone, tablet, or personal computer with high speed internet

• Participate in an informed consent process with the surgeon(s) including documentation of written informed consent

• Are undergoing a low-risk* eyelid procedure in a clinic, ambulatory surgery center, or hospital operating room setting, including but not limited to:

• upper eyelid blepharoplasty repair

• ectropion repair

• entropion repair

• external levator resection

• internal levator resection

• eyelid lesion removal and/or biopsy

• eyelid reconstruction and defect repair including after Mohs' surgery

• eyelid tightening procedures for Floppy Eyelid Syndrome

• tarsorrhaphy

• dacryocystorhinostomy

• (*)These listed procedures have a low reported rate of serious complications including vision loss, infection, severe bleeding, or death; however, surgical risk is ultimately determined by the surgeon on a per-patient basis, except in those cases specifically excluded in the subsequent section.

Locations
United States
California
University of California, San Francisco
San Francisco
Contact Information
Primary
Davin C Ashraf, MD
davin.ashraf@ucsf.edu
415-353-2800
Time Frame
Start Date: July 1, 2021
Completion Date: July 2021
Participants
Target number of participants: 100
Treatments
Experimental: Telemedicine
Patients in the telemedicine arm will have their post-operative week one visit via a telemedicine portal.
No Intervention: Routine
Patient in the routine arm will have their post-operative week one visit in clinic.
Sponsors
Leads: University of California, San Francisco

This content was sourced from clinicaltrials.gov

Similar Clinical Trials